Today: 7 February 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Vistra stock rises as VST launches secured notes sale to help fund Cogentrix dealIRVING,

Vistra stock rises as VST launches secured notes sale to help fund Cogentrix dealIRVING,

Texas, Jan 12, 2026, 09:05 CST Vistra Corp said Monday it kicked off a private sale of senior secured notes maturing in 2031 and 2036. The move aims to raise capital to back a significant acquisition. Shares of the U.S. power producer gained about 2.6%, reaching $170.71. https://www.stocktitan.net/news/VST/vistra-announces-private-offering-of-senior-secured-b9u2r3xwv1i3.html The bond sale is crucial as Vistra prepares to fund its acquisition of gas-fired generator Cogentrix Energy while maintaining balance sheet flexibility. The company plans to use the proceeds partly to cover the Cogentrix deal, pay down existing debt, and cover fees related to the offering. https://www.prnewswire.com/news-releases/vistra-announces-private-offering-of-senior-secured-notes-302658525.html Vistra last week struck a
12 January 2026
····
Google Gemini adds Walmart checkout: Alphabet’s new AI shopping push puts GOOGL stock in focus

Google Gemini adds Walmart checkout: Alphabet’s new AI shopping push puts GOOGL stock in focus

NEW YORK, Jan 12, 2026, 10:02 EST Walmart shares gained roughly 2% Monday as Alphabet slipped, following news the retailer’s shopping experience will be integrated into Google’s Gemini assistant. Shoppers can now build carts and complete checkout without leaving the chat interface. “We aren’t just watching the shift, we are driving it,” said John Furner, Walmart U.S. chief and incoming CEO. (https://corporate.walmart.com/news/2026/01/11/walmart-and-google-turn-ai-discovery-into-effortless-shopping-experiences) Google’s latest move is crucial as it aims to lock in high-intent shopping—and the ads tied to it—within its AI platforms, responding to consumers shifting from keyword searches to conversational tools. The company introduced the Universal Commerce Protocol,
12 January 2026
······
Duolingo stock sinks on CFO exit, new finance chief pay package and early Q4 user update

Duolingo stock sinks on CFO exit, new finance chief pay package and early Q4 user update

NEW YORK, Jan 12, 2026, 10:19 AM EST — Regular session Duolingo shares dropped roughly 7% Monday following the announcement that CFO Matt Skaruppa is stepping down. The language app company also released a preliminary update on its Q4 operating metrics. (Reuters) This move is significant as Duolingo has relied on consistent execution and strict cost management to back its premium subscription model. A change in CFO can rattle investors, even if the core product narrative remains strong. The timing is notable as the company shifts focus back to user growth and teaching quality, offering only a limited early glimpse
12 January 2026
·····
Klarna Group plc stock (KLAR) slides as Trump’s 10% credit-card cap talk jolts lenders, lawsuit deadline looms

Klarna Group plc stock (KLAR) slides as Trump’s 10% credit-card cap talk jolts lenders, lawsuit deadline looms

New York, Jan 12, 2026, 10:18 (ET) — Regular session Klarna Group plc shares dropped 4.8% to $29.96 in early Monday trading, down from an opening price of $32.33, as investors digested new policy risks tied to U.S. consumer lending and increased legal scrutiny on the recently listed fintech. (Investing.com) The shift follows U.S. President Donald Trump’s proposal to cap credit-card interest rates at 10% for one year beginning Jan. 20. Wall Street experts warned that such a wide-ranging cap would almost certainly need Congress approval, with slim chances of making it through. Still, the announcement rattled stocks in lenders
12 January 2026
····
Teva stock jumps after $500 million Royalty Pharma deal as investors eye JPM update

Teva stock jumps after $500 million Royalty Pharma deal as investors eye JPM update

New York, Jan 12, 2026, 10:13 ET — Regular session Teva Pharmaceutical Industries’ U.S.-listed shares jumped roughly 4% to $33.29 in Monday morning trading. The boost came after the drugmaker unveiled new funding for an experimental vitiligo treatment and offered a glimpse of its year-end outlook. This move is crucial as Teva aims to prove to investors that its growth story is both genuine and well-funded, even as it ramps up focus on branded medicines and a late-stage pipeline amid a hefty debt load. The timing is notable, arriving right before a crucial investor week when major pharmaceutical companies take
12 January 2026
·····
Moderna (MRNA) stock slips after $1.9B 2025 revenue view and cost cuts — what to watch next

Moderna (MRNA) stock slips after $1.9B 2025 revenue view and cost cuts — what to watch next

New York, January 12, 2026, 09:55 EST — Regular session Moderna (MRNA.O) shares dropped about 2% to $33.60 early Monday after the biotech forecasted around $1.9 billion in revenue for 2025 and lowered its GAAP operating-expense forecast for that year—the U.S. accounting standard. The stock swung between $35.77 and $33.33 in a volatile session. (ACCESS Newswire) This update is crucial as Moderna strives to reassure investors it can sustain itself on seasonal vaccine revenues and an expanding pipeline, rather than relying on pandemic-era demand. Traders are fixated on cash levels and how quickly the company is cutting expenses. The timing
12 January 2026
·····
SNCY stock jumps on Allegiant’s $1.5 billion bid — deal spread, regulators in focus

SNCY stock jumps on Allegiant’s $1.5 billion bid — deal spread, regulators in focus

New York, Jan 12, 2026, 09:49 AM ET — Regular session Shares of Sun Country Airlines Holdings (SNCY) jumped in early U.S. trading Monday after Allegiant Travel (ALGT) announced plans to acquire the airline in a roughly $1.5 billion deal, debt included. Sun Country’s stock rose 12.8% to $17.79, while Allegiant’s dipped 3.9% to $91.24. (Reuters) Sun Country investors aren’t just betting on an airline anymore. The stock’s price now hinges on whether the deal goes through—and how Allegiant’s shares move in the meantime. This move drags a smaller carrier into the consolidation race amid persistent cost pressures and fierce
12 January 2026
·····
Synchrony Financial stock slides on Trump’s 10% credit-card rate cap push — what to know now

Synchrony Financial stock slides on Trump’s 10% credit-card rate cap push — what to know now

NEW YORK, Jan 12, 2026, 09:51 EST — Regular session Synchrony Financial shares were down about 7% at $80.80 on Monday morning, as investors sold credit-card lenders after President Donald Trump called for a one-year cap on credit-card interest rates. The proposal matters for Synchrony because it leans heavily on interest income from store and co-branded cards. A hard cap would compress what lenders earn on revolving balances, just as the sector heads into a fresh earnings cycle. Trump said on Friday he was calling for a 10% cap starting Jan. 20, but offered no details on how the plan
12 January 2026
····
Affirm stock gives up premarket pop after Trump backs 10% credit-card rate cap

Affirm stock gives up premarket pop after Trump backs 10% credit-card rate cap

New York, Jan 12, 2026, 09:48 EST — Regular session Affirm Holdings’ shares slipped roughly 0.4% to $81.45 on Monday, after fluctuating between $80.90 and $84.65 in initial trades. The stock closed at $81.80 on Friday. (Investing.com) Shares dropped after President Donald Trump proposed a one-year cap on credit-card APRs at 10%. The idea hit bank and card-lender stocks but briefly boosted some alternative finance firms. Affirm climbed as much as 5% in premarket, though investors doubted the plan’s chances. Jefferies analysts called it “dead on arrival,” saying no executive power can enforce it alone. JPMorgan’s Vivek Juneja warned it
12 January 2026
···
Abercrombie & Fitch stock dives after holiday update trims sales outlook — what investors watch next

Abercrombie & Fitch stock dives after holiday update trims sales outlook — what investors watch next

NEW YORK, Jan 12, 2026, 09:49 EST — Regular session Abercrombie & Fitch Co shares plunged Monday after the apparel retailer trimmed its Q4 outlook and cut the upper range of its full-year sales growth forecast post-holiday season. Early trading saw the stock drop roughly 20% to $99.62. This shift is critical since the holiday quarter is prime time for many mall-based brands, and guidance changes tend to ripple quickly through the sector. Abercrombie has maintained solid margins, so expectations were already set high. Tariffs are back on the radar as shoppers stay price-conscious. Investors aren’t just focused on holiday
12 January 2026
·····
Atara Biotherapeutics stock dives on FDA EBVALLO rejection — what ATRA investors watch next

Atara Biotherapeutics stock dives on FDA EBVALLO rejection — what ATRA investors watch next

New York, Jan 12, 2026, 09:54 EST — Regular session Atara Biotherapeutics shares plunged about 56% to $6.03 in early trading after the U.S. Food and Drug Administration rejected its cell therapy tabelecleucel, marketed as EBVALLO in Europe, for a rare post-transplant cancer. The stock was volatile, swinging between $4.77 and $15.40 as investors reacted to the news, with volume exceeding 1.4 million shares. (Reuters) The company said the FDA’s complete response letter — the agency’s formal notice that an application cannot be approved as submitted — came after the Jan. 9 market close. It confirmed previous Good Manufacturing Practice
12 January 2026
·····
30,000 Homes Without Water: Major Incident Declared in Kent as South East Water Scrambles

30,000 Homes Without Water: Major Incident Declared in Kent as South East Water Scrambles

LONDON, Jan 12, 2026, 14:24 (GMT) Kent County Council declared a major incident on Monday as roughly 30,000 homes across parts of Kent and Sussex lost running water or experienced a severe drop in pressure. The disruption spilled into the start of the week, forcing some schools to close and public services to pivot while households line up for bottled water. For local officials, it’s turned into an emergency-planning challenge just as much as a plumbing issue. The sector is already facing political heat, with outages and leaks under intense scrutiny. Companies are being pressured to prove they can maintain
12 January 2026
·
1 … 327 328 329 330 331 … 884

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Go toTop